Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.4800
-0.0200
(-0.57%)
At close: 4:00:02 PM EST
3.4800
0.00
(0.00%)
After hours: 4:19:31 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 3 | 6 | 5 |
| Avg. Estimate | -0.1 | -0.15 | -0.58 | -0.44 |
| Low Estimate | -0.11 | -0.18 | -0.59 | -0.63 |
| High Estimate | -0.08 | -0.12 | -0.56 | -0.28 |
| Year Ago EPS | -0.14 | -0.19 | -0.51 | -0.58 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 3 | 8 | 7 |
| Avg. Estimate | 10.13M | 6.53M | 25.75M | 45.98M |
| Low Estimate | 5.78M | 3.44M | 21.37M | 26.8M |
| High Estimate | 12.64M | 10M | 28.22M | 69M |
| Year Ago Sales | 4.82M | 3.8M | 34.16M | 25.75M |
| Sales Growth (year/est) | 110.07% | 71.91% | -24.64% | 78.60% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.15 | -0.16 | -0.17 | -0.14 |
| EPS Actual | -0.14 | -0.19 | -0.13 | -0.16 |
| Difference | 0.01 | -0.03 | 0.04 | -0.02 |
| Surprise % | 8.41% | -16.33% | 25.00% | -17.07% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.15 | -0.58 | -0.44 |
| 7 Days Ago | -0.1 | -0.15 | -0.58 | -0.44 |
| 30 Days Ago | -0.1 | -0.15 | -0.58 | -0.44 |
| 60 Days Ago | -0.09 | -0.15 | -0.58 | -0.43 |
| 90 Days Ago | -0.1 | -0.14 | -0.57 | -0.43 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | -- | 1 | 1 |
| Up Last 30 Days | 2 | -- | 1 | 1 |
| Down Last 7 Days | 1 | 1 | -- | 2 |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OABI | 30.95% | 21.05% | -13.40% | 24.61% |
| S&P 500 | 16.00% | 7.22% | 10.60% | 14.10% |
Upgrades & Downgrades
| Reiterates | Benchmark: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Reiterates | Benchmark: Buy to Buy | 8/19/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 8/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/12/2024 |
| Reiterates | Benchmark: Buy to Buy | 5/14/2024 |
Related Tickers
LGND Ligand Pharmaceuticals Incorporated
122.23
+5.67%
ARMP Armata Pharmaceuticals, Inc.
1.9853
-4.55%
GNFT Genfit S.A.
3.4700
-1.98%
XOMA XOMA Royalty Corporation
22.70
0.00%
PVLA Palvella Therapeutics, Inc.
19.37
+2.76%
NBTX Nanobiotix S.A.
3.5100
-4.10%
ARTV Artiva Biotherapeutics, Inc.
4.1500
+11.26%
KRON Kronos Bio, Inc.
0.9800
+1.53%
IVA Inventiva S.A.
3.1700
-2.76%
MEIP MEI Pharma, Inc.
2.5600
-2.29%